Home » Posts tagged with » Olema Oncology
Olema Oncology to evaluate OP-1250, palbociclib combo in advanced breast cancer
Olema Oncology has entered into a clinical trial agreement with Pfizer to evaluate its small molecule OP-1250 in combination with the latter’s palbociclib (IBRANCE) in advanced breast cancer. OP-1250 is an estrogen receptor (ER) antagonist (CERAN) and a selective ER degrader (SERD). Its combination with the Pfizer breast cancer drug will be assessed in the […]
Olema Oncology, a California-based biopharma company focused on developing targeted therapies for women’s cancers, has raised $54 million in a Series B financing round, which was co-led by BVF Partners, Logos Capital, and Janus Henderson Investors. The US biopharma company will use the proceeds for advancing OP-1250, its lead drug candidate in breast cancer, into […]
Continue reading …
Business News Today
- Castle Mountain Gold Mine California : Equinox Gold achieves commercial production
- McCormick to acquire Mexican hot sauce brand Cholula Hot Sauce
- Elliott Advisors offers to take over Swiss food company Aryzta for CHF0.8 per share
- US challenger bank Current raises $131m in Series C round
- HelloFresh to acquire US meal delivery service provider Factor75
- Wheelock Street Capital acquires Hotel Contessa in San Antonio
- Visa acquires digital financial solutions provider YellowPepper
- OnPoint Community Credit Union to open 20 branches in Fred Meyer stores
- Union Pacific Intermodal Terminal to provide intermodal service to Minneapolis
- Victory Metals Nevada King merger to create major gold company in Nevada
